Found: 745
Select item for more details and to access through your institution.
Current insights into the Pathophysiology of kidney diseases.
- Published in:
- Acta Physiologica, 2024, v. 240, n. 7, p. 1, doi. 10.1111/apha.14158
- By:
- Publication type:
- Article
Revisiting the interaction between complement lectin pathway protease MASP-2 and SARS-CoV-2 nucleoprotein.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1419165
- By:
- Publication type:
- Article
Clinical efficacy and safety of switching from eculizumab to ravulizumab in adult patients with aHUS– real-world data.
- Published in:
- BMC Nephrology, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12882-024-03638-3
- By:
- Publication type:
- Article
Urinary complement biomarkers in immune-mediated kidney diseases.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1357869
- By:
- Publication type:
- Article
The histone demethylase JMJD1C regulates CPS1 expression and promotes the proliferation of paroxysmal nocturnal haemoglobinuria clones through cell metabolic reprogramming.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 6, p. 2468, doi. 10.1111/bjh.19477
- By:
- Publication type:
- Article
Monoclonal antibodies that target fibroblast growth factor receptor 2 isoform b and Claudin‐18 isoform 2 splicing variants in gastric cancer and other solid tumours.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 6, p. 1, doi. 10.1002/ctm2.1736
- By:
- Publication type:
- Article
Safety and Efficacy of Very Early Conversion to Belatacept in Pediatric Kidney Transplantation with Transplant-Associated Thrombotic Microangiopathy: Case Study and Review of Literature.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Targeted complement inhibition using bispecific antibodies that bind local antigens and endogenous complement regulators.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1288597
- By:
- Publication type:
- Article
Plasmodium falciparum Glutamic Acid-Rich Protein-Independent Polyclonal Antibodies Inhibit Malaria Parasite Growth in Human Erythrocytes.
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, n. 5, p. 1565, doi. 10.1093/infdis/jiae050
- By:
- Publication type:
- Article
Multifunctional interaction of CihC/FbpC orthologs of relapsing fever spirochetes with host-derived proteins involved in adhesion, fibrinolysis, and complement evasion.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1390468
- By:
- Publication type:
- Article
The C1q and gC1qR axis as a novel checkpoint inhibitor in cancer.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1351656
- By:
- Publication type:
- Article
Mapping the interaction sites of human and avian influenza A viruses and complement factor H.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1352022
- By:
- Publication type:
- Article
Hereditary angioedema with normal C1 esterase inhibitor: Current paradigms and clinical dilemmas.
- Published in:
- Allergy & Asthma Proceedings, 2024, v. 45, n. 3, p. 147, doi. 10.2500/aap.2024.45.240010
- By:
- Publication type:
- Article
Real‐world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis.
- Published in:
- Annals of Clinical & Translational Neurology, 2024, v. 11, n. 5, p. 1338, doi. 10.1002/acn3.52051
- By:
- Publication type:
- Article
Relationship of Hematological Profiles with the Serum Complement System in Patients with Systemic Lupus Erythematosus.
- Published in:
- Biomedicines, 2024, v. 12, n. 5, p. 967, doi. 10.3390/biomedicines12050967
- By:
- Publication type:
- Article
Eculizumab dose tapering should take into account the nonlinearity of its pharmacokinetics.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 5, p. 1312, doi. 10.1111/bcp.16019
- By:
- Publication type:
- Article
Eculizumab for paroxysmal nocturnal hemoglobinuria: Two cases of successful pregnancy outcomes.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Biologics and Non-Biologics Immunosuppressive Treatments for IgA Nephropathy in Both Adults and Children.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 9, p. 2465, doi. 10.3390/jcm13092465
- By:
- Publication type:
- Article
The efficacy and safety of FcRn inhibitors in patients with myasthenia gravis: a systematic review and meta-analysis.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 5, p. 2298, doi. 10.1007/s00415-024-12247-x
- By:
- Publication type:
- Article
Newly emerging type B insulin resistance (TBIR) during treatment with eculizumab for AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD): fatal outcome.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 5, p. 2866, doi. 10.1007/s00415-023-12071-9
- By:
- Publication type:
- Article
Dramatic improvement in refractory myasthenia gravis with eculizumab treatment: a case report.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 5, p. 2902, doi. 10.1007/s00415-024-12245-z
- By:
- Publication type:
- Article
Crystal structure of Trichinella spiralis calreticulin and the structural basis of its complement evasion mechanism involving C1q.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1404752
- By:
- Publication type:
- Article
Ginsenoside Rh2 shifts tumor metabolism from aerobic glycolysis to oxidative phosphorylation through regulating the HIF1-α/PDK4 axis in non-small cell lung cancer.
- Published in:
- Molecular Medicine, 2024, v. 30, n. 1, p. 1, doi. 10.1186/s10020-024-00813-y
- By:
- Publication type:
- Article
Complement propagates visual system pathology following traumatic brain injury.
- Published in:
- Journal of Neuroinflammation, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12974-024-03098-4
- By:
- Publication type:
- Article
STING inhibition suppresses microglia-mediated synapses engulfment and alleviates motor functional deficits after stroke.
- Published in:
- Journal of Neuroinflammation, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12974-024-03086-8
- By:
- Publication type:
- Article
Role of PIGM and PIGX in glycosylphosphatidylinositol biosynthesis and human health (Review).
- Published in:
- Biomedical Reports, 2024, v. 20, n. 4, p. N.PAG, doi. 10.3892/br.2024.1746
- By:
- Publication type:
- Article
Plain language summary on long‐term effectiveness of eculizumab: Data from the International PNH Registry.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 4, p. 658, doi. 10.1111/ejh.14150
- Publication type:
- Article
Reduced expressions of apoptosis-related proteins TRAIL, Bcl-2, and TNFR1 in NK cells of juvenile-onset systemic lupus erythematosus patients: relations with disease activity, nephritis, and neuropsychiatric involvement.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1327255
- By:
- Publication type:
- Article
Editorial: Women in cytokines and soluble mediators in immunity.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1395165
- By:
- Publication type:
- Article
SAP-expressing T peripheral helper cells identify systemic lupus erythematosus patients with lupus nephritis.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1327437
- By:
- Publication type:
- Article
Protective role of complement factor H against the development of preeclampsia.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1351898
- By:
- Publication type:
- Article
Warm autoimmune hemolytic anemia associated with SARS-CoV-2 infection responsive to eculizumab.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 3, p. 1007, doi. 10.1007/s00277-023-05549-z
- By:
- Publication type:
- Article
Immune Gene Networks from Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.
- Published in:
- Biomedicines, 2024, v. 12, n. 3, p. 628, doi. 10.3390/biomedicines12030628
- By:
- Publication type:
- Article
The Production of Complement Inhibitor Proteins in Mammalian Cell Lines—Light at the End of the Tunnel?
- Published in:
- Biomedicines, 2024, v. 12, n. 3, p. 646, doi. 10.3390/biomedicines12030646
- By:
- Publication type:
- Article
Eculizumab as Additional Rescue Therapy in Myasthenic Crisis.
- Published in:
- Muscles (2813-0413), 2024, v. 3, n. 1, p. 40, doi. 10.3390/muscles3010005
- By:
- Publication type:
- Article
Eculizumab for myasthenic exacerbation during treatment with immune-checkpoint inhibitors.
- Published in:
- Neurological Sciences, 2024, v. 45, n. 3, p. 1243, doi. 10.1007/s10072-023-07190-0
- By:
- Publication type:
- Article
Efficacy and Safety of Eculizumab in Enteroaggregative E. coli Associated Hemolytic Uremic Syndrome.
- Published in:
- Pediatric Reports, 2024, v. 16, n. 1, p. 26, doi. 10.3390/pediatric16010003
- By:
- Publication type:
- Article
C1q enables influenza hemagglutinin stem binding antibodies to block viral attachment and broadens the antibody escape repertoire.
- Published in:
- Science Immunology, 2024, v. 9, n. 93, p. 1, doi. 10.1126/sciimmunol.adj9534
- By:
- Publication type:
- Article
The human factor H protein family -- an update.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1135490
- By:
- Publication type:
- Article
A proteomic classifier panel for early screening of colorectal cancer: a case control study.
- Published in:
- Journal of Translational Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12967-024-04983-5
- By:
- Publication type:
- Article
A novel complement C3 inhibitor CP40-KK protects against experimental pulmonary arterial hypertension via an inflammasome NLRP3 associated pathway.
- Published in:
- Journal of Translational Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12967-023-04741-z
- By:
- Publication type:
- Article
Mechanisms by which Factor H protects Trypanosoma cruzi from the alternative pathway of complement.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1152000
- By:
- Publication type:
- Article
Immediate and sustained terminal complement inhibition with ravulizumab in patients with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.
- Published in:
- Frontiers in Neurology, 2024, p. 1, doi. 10.3389/fneur.2024.1332890
- By:
- Publication type:
- Article
Single-Cell Sequencing Reveals the Expression of Immune-Related Genes in Macrophages of Diabetic Kidney Disease.
- Published in:
- Inflammation, 2024, v. 47, n. 1, p. 227, doi. 10.1007/s10753-023-01906-2
- By:
- Publication type:
- Article
Suppression of CDC42 potential in breast cancer tumor microenvironment by tumor necrosis factor inhibitors.
- Published in:
- International Journal of Rheumatic Diseases, 2024, v. 27, n. 2, p. 1, doi. 10.1111/1756-185X.14934
- By:
- Publication type:
- Article
C3G and Ig-MPGN—treatment standard.
- Published in:
- Nephrology Dialysis Transplantation, 2024, v. 39, n. 2, p. 202, doi. 10.1093/ndt/gfad182
- By:
- Publication type:
- Article
Rational use of eculizumab in secondary atypical hemolytic uremic syndrome.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2023.1310469
- By:
- Publication type:
- Article
Interleukin-1 receptor associated kinase 2 is a functional downstream regulator of complement factor D that controls mitochondrial fitness in diabetic cardiomyopathy.
- Published in:
- Military Medical Research, 2024, v. 10, n. 1, p. 1, doi. 10.1186/s40779-023-00506-3
- By:
- Publication type:
- Article
Cell and animal models of age‐related macular degeneration: Focus on oxidative stress and protein aggregation.
- Published in:
- Acta Ophthalmologica (1755375X), 2024, v. 102, p. N.PAG, doi. 10.1111/aos.16508
- By:
- Publication type:
- Article
Vitamin D3 improved hypoxia-induced lung injury by inhibiting the complement and coagulation cascade and autophagy pathway.
- Published in:
- BMC Pulmonary Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12890-023-02784-y
- By:
- Publication type:
- Article